5 reports

Note: ##.

  • Healthcare
  • Respiratory Disease
  • World
  • Forecast
  • Adherium Limited

ESYSTA FROM EMPERRA E-HEALTH TECHNOLOGIES IS ANOTHER ONE OF THE HIGHEST-RANKING DEVICES IN THIS SEGMENT.

  • Drug Delivery
  • Respiratory Disease
  • World
  • Forecast
  • Adherium Limited

Core operating income was USD ##. ## billion (-##%, +##% cc).

  • Respiratory Disease
  • United States
  • Company
  • Company Financials
  • Orion Corporation

The record date will be September ##, 2016 and the payment date will be September ##, 2016.

  • Pharmaceutical
  • Respiratory Disease
  • Company Financials
  • Market Size
  • Teva Pharmaceutical Industries Ltd.
  • ZCUBE DEVICE - CHRONIC RESPIRATORY DISEASE - PRODUCT STATUS
  • ZCUBE DEVICE - CHRONIC RESPIRATORY DISEASE - PRODUCT DESCRIPTION

Z-Cube also invests in drug delivery systems applicable to prescription and over the counter products, medical devices and digital healthcare.

  • Clinical Trial
  • Hospital
  • Respiratory Disease
  • Therapy
  • Getinge Group